InMed Pharmaceuticals, Inc. (INM)
1.40
+0.05
(+3.70%)
USD |
NASDAQ |
Sep 03, 12:55
InMed Pharmaceuticals Cash from Investing (Quarterly) : 0.00 for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.0001M |
| March 31, 2024 | -0.0001M |
| December 31, 2023 | -0.0092M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | -0.0411M |
| March 31, 2023 | -0.1286M |
| December 31, 2022 | -0.4904M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -0.7193M |
| March 31, 2022 | -0.0039M |
| December 31, 2021 | 0.306M |
| September 30, 2021 | -0.25M |
| June 30, 2021 | -0.0018M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | -0.0699M |
| March 31, 2020 | -0.0106M |
| Date | Value |
|---|---|
| December 31, 2019 | -0.0005M |
| September 30, 2019 | 3.754M |
| June 30, 2019 | 1.730M |
| March 31, 2019 | 0.0214M |
| December 31, 2018 | 0.0321M |
| September 30, 2018 | -3.850M |
| June 30, 2018 | 0.0385M |
| March 31, 2018 | -1.854M |
| December 31, 2017 | -0.0282M |
| September 30, 2017 | -0.0035M |
| June 30, 2017 | -0.0074M |
| March 31, 2017 | -0.0115M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.0254M |
| March 31, 2016 | -0.0255M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | -0.0009M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.0004M |
| December 31, 2014 | -0.0053M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | -0.002M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| NervGen Pharma Corp. | -0.0001M |
| Milestone Pharmaceuticals, Inc. | 111.84M |
| Clearmind Medicine, Inc. | -0.6541M |
| Lexaria Bioscience Corp. | -0.0271M |
| Target Group, Inc. (Canada) | -0.0065M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.759M |
| Cash from Financing (Quarterly) | 0.2315M |
| Free Cash Flow | -7.710M |
| Free Cash Flow Per Share (Quarterly) | -0.4345 |
| Free Cash Flow to Equity (Quarterly) | -1.647M |
| Free Cash Flow to Firm (Quarterly) | -1.759M |
| Free Cash Flow Yield | -157.8% |